source
- U.S. Treasury Considers New Screening Rules for Investments in Chinese BiotechTreasury Department officials are reviewing possible measures to screen U.S. capital flowing into Chinese biotechnology firms, according to multiple sources familiar with the discussions. The revi…
- Novo Nordisk expands in China and Czech; Cellares boosts Series D by $50MPlus more from Eisai and Siegfried. 🧱 Novo Nordisk's expansions: Novo Nordisk has invested around $380 million to expand its manufacturing facility in Bohumil, Central Bohemia, in the Czech Republ…Endpoints · 2mo ago↗ source